DBXS 📈 Xtrackers - Switzerland - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0274221281 • Switzerland Equity
DBXS: Swiss, Stocks, Bonds, Equities, ETFs
‣ Company URL: http://www.dws.lu ‣ Domicile: Luxembourg ‣ Index Name: Morningstar Switzerland TME NR CHF
Additional Sources for DBXS ETF
DBXS ETF Overview
| Market Cap in USD | 1,407m |
| Category | Switzerland Equity |
| TER | 0.35% |
| IPO / Inception | 2007-01-22 |
DBXS ETF Ratings
| Growth 5y | 50.6% |
| Fundamental | - |
| Dividend | 55.7% |
| Rel. Strength Industry | -82.2 |
| Analysts | - |
| Fair Price Momentum | 115.65 EUR |
| Fair Price DCF | - |
DBXS Dividends
| Dividend Yield 12m | 1.56% |
| Yield on Cost 5y | 1.99% |
| Annual Growth 5y | 11.32% |
| Payout Consistency | 91.7% |
DBXS Growth Ratios
| Growth Correlation 3m | -76% |
| Growth Correlation 12m | 66.4% |
| Growth Correlation 5y | 85% |
| CAGR 5y | 4.83% |
| CAGR/Mean DD 5y | 0.79 |
| Sharpe Ratio 12m | -0.25 |
| Alpha | -12.86 |
| Beta | 0.44 |
| Volatility | 11.49% |
| Current Volume | 21.3k |
| Average Volume 20d | 7.6k |
What is the price of DBXS stocks?
As of December 22, 2024, the stock is trading at EUR 124.88 with a total of 21,320 shares traded.
Over the past week, the price has changed by -2.45%, over one month by -1.01%, over three months by -4.22% and over the past year by +3.33%.
As of December 22, 2024, the stock is trading at EUR 124.88 with a total of 21,320 shares traded.
Over the past week, the price has changed by -2.45%, over one month by -1.01%, over three months by -4.22% and over the past year by +3.33%.
Is Xtrackers - Switzerland a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Xtrackers - Switzerland (XETRA:DBXS) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 50.64 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBXS as of December 2024 is 115.65. This means that DBXS is currently overvalued and has a potential downside of -7.39%.
Partly, yes. Based on ValueRay Analyses, Xtrackers - Switzerland (XETRA:DBXS) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 50.64 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBXS as of December 2024 is 115.65. This means that DBXS is currently overvalued and has a potential downside of -7.39%.
Is DBXS a buy, sell or hold?
Xtrackers - Switzerland has no consensus analysts rating.
Xtrackers - Switzerland has no consensus analysts rating.
What are the forecast for DBXS stock price target?
According to ValueRays Forecast Model, DBXS Xtrackers - Switzerland will be worth about 126.4 in December 2025. The stock is currently trading at 124.88. This means that the stock has a potential upside of +1.18%.
According to ValueRays Forecast Model, DBXS Xtrackers - Switzerland will be worth about 126.4 in December 2025. The stock is currently trading at 124.88. This means that the stock has a potential upside of +1.18%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 126.4 | 1.2% |